Singapore markets closed
  • Straits Times Index

    3,157.40
    -9.54 (-0.30%)
     
  • S&P 500

    4,395.26
    -23.89 (-0.54%)
     
  • Dow

    34,935.47
    -149.03 (-0.42%)
     
  • Nasdaq

    14,672.68
    -105.62 (-0.71%)
     
  • BTC-USD

    39,523.70
    -2,208.56 (-5.29%)
     
  • CMC Crypto 200

    962.84
    +12.94 (+1.36%)
     
  • FTSE 100

    7,101.12
    +68.82 (+0.98%)
     
  • Gold

    1,809.50
    -7.70 (-0.42%)
     
  • Crude Oil

    73.20
    -0.75 (-1.01%)
     
  • 10-Yr Bond

    1.2390
    0.0000 (0.00%)
     
  • Nikkei

    27,781.02
    +497.43 (+1.82%)
     
  • Hang Seng

    26,235.80
    +274.77 (+1.06%)
     
  • FTSE Bursa Malaysia

    1,490.47
    -4.13 (-0.28%)
     
  • Jakarta Composite Index

    6,096.54
    +26.50 (+0.44%)
     
  • PSE Index

    6,446.31
    +176.08 (+2.81%)
     

Last Few Days to Actively Participate Repro-Med Systems, Inc. (KRMD) Class Action - Bronstein, Gewirtz & Grossman, LLC

·2-min read

Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Repro-Med Systems, Inc. (d/b/a KORU Medical Systems) ("KORU" or "the Company") (NASDAQ: KRMD) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired KORU securities between August 4, 2020 and January 25, 2021, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/krmd.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements and failed to disclose that: (1) starting in January 2020, KORU ramped up the use of allowances, including growth rebates, to retain key customers and to incentivize growth; (2) as the rebates accrued, the Company’s net sales were reasonably likely to decline; and (3) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: www.bgandg.com/krmd or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in KORU you have until May 25, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210520005007/en/

Contacts

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting